Literature DB >> 11033590

Better access to information about clinical trials.

A T McCray1.   

Abstract

Access to information about clinical trials is important to researchers, health care professionals, and patients. Many have argued for the establishment of clinical trials registries, citing their substantial benefits. Although some registries do exist, it has been difficult to create comprehensive, easily accessible systems. This paper briefly reviews existing registries, discusses the challenges in building registries, and reviews some of their benefits. The paper concludes with a description of a new, extensive Web-based registry called ClinicalTrials.gov (http://clinicaltrials. gov/), which was developed at the National Institutes of Health (NIH) by the National Library of Medicine as a result of recent legislation calling for a comprehensive, publicly accessible registry of clinical trials. The first version of the system became available in late February 2000 and contains information about approximately 5000 trials. The first release contains primarily NIH-sponsored trials, and new trials are regularly added to the system. Subsequent versions will contain information about trials sponsored by other federal agencies and by the private sector. The system was developed in accordance with basic informatics principles, including adherence to standards, usability considerations, and iterative testing and evaluation.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2000        PMID: 11033590     DOI: 10.7326/0003-4819-133-8-200010170-00013

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  32 in total

1.  Evidence-based practice: extending the search to find material for the systematic review.

Authors:  D Helmer; I Savoie; C Green; A Kazanjian
Journal:  Bull Med Libr Assoc       Date:  2001-10

2.  Can current electronic systems meet drug safety and effectiveness requirements?

Authors:  Anne Holbrook; Paul Grootendorst; Don Willison; Charles Goldsmith; Rolf Sebaldt; Karim Keshavjee
Journal:  AMIA Annu Symp Proc       Date:  2005

3.  Rising expectations: access to biomedical information.

Authors:  D A B Lindberg; B L Humphreys
Journal:  Yearb Med Inform       Date:  2008

4.  Characterizing treatment pathways at scale using the OHDSI network.

Authors:  George Hripcsak; Patrick B Ryan; Jon D Duke; Nigam H Shah; Rae Woong Park; Vojtech Huser; Marc A Suchard; Martijn J Schuemie; Frank J DeFalco; Adler Perotte; Juan M Banda; Christian G Reich; Lisa M Schilling; Michael E Matheny; Daniella Meeker; Nicole Pratt; David Madigan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

5.  Semi-Automatically Inducing Semantic Classes of Clinical Research Eligibility Criteria Using UMLS and Hierarchical Clustering.

Authors:  Zhihui Luo; Stephen B Johnson; Chunhua Weng
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

6.  The NIAID Division of AIDS enterprise information system: integrated decision support for global clinical research programs.

Authors:  Jonathan M Kagan; Nitin Gupta; Suresh Varghese; Hemant Virkar
Journal:  J Am Med Inform Assoc       Date:  2011-08-04       Impact factor: 4.497

7.  Finding appropriate clinical trials: evaluating encoded eligibility criteria with incomplete data.

Authors:  N Ash; O Ogunyemi; Q Zeng; L Ohno-Machado
Journal:  Proc AMIA Symp       Date:  2001

Review 8.  Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.

Authors:  Edwin J Wagena; Maurice P A Zeegers; Constant P van Schayck; Emiel F M Wouters
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Characterization of the Context of Drug Concepts in Research Protocols: An Empiric Study to Guide Ontology Development.

Authors:  James J Cimino; Vojtech Huser
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

10.  From phenotype to genotype: issues in navigating the available information resources.

Authors:  J A Mitchell; A T McCray; O Bodenreider
Journal:  Methods Inf Med       Date:  2003       Impact factor: 2.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.